Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum

Because persons who identify across the transgender spectrum (PATS) are a key population in human immunodeficiency virus (HIV) yet are underreported in HIV and cardiovascular research, we aimed to characterize this population within the REPRIEVE global clinical trial (n = 7770). Acceptance of gather...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Smeaton, Laura M, Kileel, Emma M, Grinsztejn, Beatriz, Gardner, Edward M, Starr, Kate, Murry, Melissa L, Desvigne-Nickens, Patrice, Alston-Smith, Beverly, Waclawiw, Myron A, Cooper-Arnold, Katharine, Madruga, José V, Sangle, Shashi, Fitch, Kathleen V, Zanni, Markella V, Douglas, Pamela S, Ribaudo, Heather J, Grinspoon, Steven K, Klingman, Karin L
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Supplement Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347077/
https://ncbi.nlm.nih.gov/pubmed/32645160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa213
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares